NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 12, 2026 3:59:58 PM EDT
38.58USD-0.155%(-0.06)8,278,983
Pre-marketOct 12, 2026 9:29:30 AM EDT
38.87USD+0.595%(+0.23)
After-hoursOct 12, 2026 4:56:30 PM EDT
38.63USD+0.141%(+0.05)
Loading…
Loading…
170.46B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$38.64
Beta
1.04
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$43.43
SMA 200
$45.40
Avg. Vol 10D
13.28M
Avg. Vol 30D
13.22M
Avg. Vol 90D
12.62M
Relative Vol
0.56
4.41B
3.17B
71.88%
31,622,458
1.00%
1.74
54%/46%
45.08%
25.83%
0.2900%
10,000,000
13,000
149,184
637,798
Nov 4, 2026 (23d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 12, 2026
This week’s top stock pitches from investment newsletters. · 
Stock Analysis Compilation
GLP-1s in Ireland: How weight-loss medications work under the HSE system · 
The Irish Times
4 Healthcare Stocks Worth Owning for the Next Decade · 
The Motley Fool
BMO cuts Novo Nordisk stock price target on Ozempic headwinds · 
Investing.com
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 37.54 | 2026-10-05 | +2.86% | -0.029 |
| 1M | 43.07 | 2026-09-11 | -10.34% | -0.346 |
| 3M | 49.28 | 2026-07-13 | -21.64% | -0.300 |
| 6M | 37.98 | 2026-04-13 | +1.67% | 0.180 |
| 1Y | 57.50 | 2025-10-13 | -32.84% | 1.041 |
| 2Y | 120.04 | 2024-10-11 | -67.83% | — |
| 5Y | 48.82 | 2021-10-12 | -20.90% | 0.673 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $38.62, and today's volume is 7,402,534. NVO is down 0.065% today. The 30 day average volume is 13.22M. NVO market cap is $170.46B with 4.41B shares outstanding.